Advertisement

Made-in-Canada vaccine touted by province still in early stages: Winnipeg epidemiologist

Click to play video: 'Prime Minister, experts respond to Manitoba’s plan to buy its own COVID-19 vaccines' Prime Minister, experts respond to Manitoba’s plan to buy its own COVID-19 vaccines
Manitoba's premier announced Thursday the province would skirt the federal government and purchase 2-million doses of a made-in-Canada alternative. Global's Marney Blunt has more on what the Prime Minister and other experts think of the move – Feb 12, 2021

Manitoba Premier Brian Pallister announced Thursday that the province has committed to purchasing two million doses of a made-in-Canada COVID-19 vaccine, but the fact that the vaccine in question is still in the early stages of a clinical trial has raised a few eyebrows.

Winnipeg epidemiologist Cynthia Carr of EPI Research told 680 CJOB it should be noted that the Alberta-based company, Providence Therapeutics, still has a ways to go before its vaccine gets approved by Health Canada.

“They are so early in the process,” Carr said.

“They have a Phase 1 human trial with 60 people. They don’t have approval yet to proceed with Phase 2, which would start in May. After that trial is completed, they would have to go through the federal process of review and approval,” she continued.

“Then they have to manufacture and distribute those vaccines. With this company, do they have the capacity to do that? We see these huge Fortune 500 companies having challenges in capacities.”

Story continues below advertisement

Read more: 1,200 additional coronavirus vaccine doses available for Manitoba First Nations: health officials

Alberta Premier Jason Kenney is another premier that has floated the idea of securing their own vaccine supply.

“What they have in common is that they are not terribly popular when it comes to their handling of COVID,” University of Calgary public policy professor Lisa Young told Global News of the two premiers.

“If we look at the approval ratings for how well the provinces handled COVID, Manitoba and Alberta are at the bottom of the barrel.”

Click to play video: 'Coronavirus: Manitoba Premier Pallister says approval ratings are low because ‘people don’t like COVID’' Coronavirus: Manitoba Premier Pallister says approval ratings are low because ‘people don’t like COVID’
Coronavirus: Manitoba Premier Pallister says approval ratings are low because ‘people don’t like COVID’ – Dec 1, 2020

“Because of this, the premier really does need a win,” she added. “I think the premier wants to be a hero in the face of the COVID crisis, and it’s pretty clear that getting vaccines into arms is going to be the best way to be seen to be effective in this stage of managing the pandemic.”

Story continues below advertisement

Read more: Canada’s vaccinations are lagging U.S., U.K.. Why experts say that shouldn’t be the focus

The CEO of Providence Therapeutics said if everything goes according to plan, his company’s vaccine could be approved for emergency use by Health Canada by this fall.

In a release on Jan. 26, Providence said the vaccine, dubbed PTX-COVID19-B, is a messenger RNA (mRNA) vaccine, and is the first fully made-in-Canada vaccine to reach the human clinical trial stage.

Pallister wouldn’t say exactly how much the province has agreed to pay, but did say the agreement will see Manitoba putting 20 per cent down, with another 40 per cent coming on approval by Health Canada and the final 40 per cent coming on delivery.

“We’ll release the details of the contract when it’s finalized,” he said.

“Manitobans are Canadians first. We are investing not just for ourselves, but for all Canadians,” he said. “Building a secure, made-in-Canada vaccine supply will put Canadians at the head of the line to get a COVID vaccine, where we belong.”

— With files from Marney Blunt

Click to play video: 'Coronavirus: Manitoba agrees to purchase 2M doses of Providence Therapeutics COVID-19 vaccine' Coronavirus: Manitoba agrees to purchase 2M doses of Providence Therapeutics COVID-19 vaccine
Coronavirus: Manitoba agrees to purchase 2M doses of Providence Therapeutics COVID-19 vaccine – Feb 11, 2021
Story continues below advertisement

 

Sponsored content